SGRL Q1 FY27 results at a glance
Shree Ganesh Remedies Limited Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹14.36 cr |
|---|
| Revenue YoY | -41.8% |
|---|
| Operating profit | ₹0.91 cr |
|---|
| Operating margin | 6.3% |
|---|
| Net profit | ₹1.12 cr |
|---|
| Net profit YoY | -67.5% |
|---|
| Net profit QoQ | -82.1% |
|---|
| Net margin | 7.8% |
|---|
| Basic EPS | ₹0.87 |
|---|
| TTM revenue | ₹98.98 cr |
|---|
| TTM net profit | ₹15.44 cr |
|---|
| TTM net margin | 15.6% |
|---|
SGRL Q1 FY27 results: what the numbers say
Shree Ganesh Remedies Limited (SGRL) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹14.36 cr and a net profit of ₹1.12 cr, translating into earnings per share of ₹0.87.
Compared with the same quarter a year earlier, revenue declined strongly by -41.8% and net profit declined sharply by -67.5%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹0.91 cr, an operating margin of 6.3% versus 19.8% a year ago — a contraction of 13.4 percentage points.
SGRL quarter-wise results table
Revenue
₹14.36 cr
-41.8% YoY
Net profit
₹1.12 cr
-67.5% YoY
Operating profit
₹0.91 cr
-81.3% YoY
Shree Ganesh Remedies Limited (SGRL) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹14.36 cr | ₹0.91 cr | ₹1.12 cr | 6.3% | 7.8% | ₹0.87 | -67.5% | -82.1% |
| Q4 FY262026-03-31 | ₹33.2 cr | ₹8.57 cr | ₹6.27 cr | 25.8% | 18.9% | ₹4.88 | — | +102.9% |
| Q3 FY262025-12-31 | ₹21.11 cr | ₹4.06 cr | ₹3.09 cr | 19.2% | 14.6% | ₹2.41 | — | -37.6% |
| Q2 FY262025-09-30 | ₹30.32 cr | ₹7.03 cr | ₹4.96 cr | 23.2% | 16.3% | ₹3.86 | — | +43.8% |
| Q1 FY262025-06-30 | ₹24.67 cr | ₹4.88 cr | ₹3.45 cr | 19.8% | 14.0% | ₹2.68 | — | — |
| TTM (last 4 quarters) | ₹98.98 cr | ₹20.58 cr | ₹15.44 cr | 20.8% | 15.6% | ₹12.02 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
SGRL quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
Shree Ganesh Remedies Limited quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹14.36 cr | ₹33.2 cr | ₹21.11 cr | ₹30.32 cr | ₹24.67 cr |
|---|
| Total expenses | ₹13.45 cr | ₹24.62 cr | ₹17.04 cr | ₹23.28 cr | ₹19.79 cr |
|---|
| Gross profit | ₹12.27 cr | ₹18.97 cr | ₹14.77 cr | ₹17.72 cr | ₹15.94 cr |
|---|
| Operating profit (EBIT) | ₹0.91 cr | ₹8.57 cr | ₹4.06 cr | ₹7.03 cr | ₹4.88 cr |
|---|
| Operating margin | 6.3% | 25.8% | 19.2% | 23.2% | 19.8% |
|---|
| Interest cost | ₹0.32 cr | ₹0.88 cr | ₹0.74 cr | ₹1.01 cr | ₹0.94 cr |
|---|
| Profit before tax | ₹1.53 cr | ₹8.72 cr | ₹3.98 cr | ₹6.71 cr | ₹4.6 cr |
|---|
| Tax expense | ₹0.41 cr | ₹2.45 cr | ₹0.89 cr | ₹1.76 cr | ₹1.15 cr |
|---|
| Effective tax rate | 26.8% | 28.1% | 22.4% | 26.2% | 25.1% |
|---|
| Net profit (PAT) | ₹1.12 cr | ₹6.27 cr | ₹3.09 cr | ₹4.96 cr | ₹3.45 cr |
|---|
| Net profit margin | 7.8% | 18.9% | 14.6% | 16.3% | 14.0% |
|---|
| Basic EPS | ₹0.87 | ₹4.88 | ₹2.41 | ₹3.86 | ₹2.68 |
|---|
| Diluted EPS | ₹0.87 | ₹4.88 | ₹2.41 | ₹3.86 | ₹2.68 |
|---|
SGRL results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | -41.8% | — | — | — | — |
|---|
| Revenue QoQ | -56.7% | +57.3% | -30.4% | +22.9% | — |
|---|
| Operating profit YoY | -81.3% | — | — | — | — |
|---|
| Operating profit QoQ | -89.4% | +111.0% | -42.2% | +44.2% | — |
|---|
| Net profit YoY | -67.5% | — | — | — | — |
|---|
| Net profit QoQ | -82.1% | +102.9% | -37.6% | +43.8% | — |
|---|
| EPS YoY | -67.5% | — | — | — | — |
|---|
| EPS QoQ | -82.2% | +102.5% | -37.6% | +44.0% | — |
|---|
SGRL annual results history
Full-year performance for Shree Ganesh Remedies Limited, useful for reading each quarter in context.
Shree Ganesh Remedies Limited annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹108 cr | ₹107 cr | ₹125 cr | ₹90.22 cr |
|---|
| Total expenses | ₹83.01 cr | ₹76.31 cr | ₹89.1 cr | ₹69.91 cr |
|---|
| Gross profit | ₹66.01 cr | ₹70.33 cr | ₹66.32 cr | ₹43.06 cr |
|---|
| Operating profit (EBIT) | ₹25.08 cr | ₹30.19 cr | ₹35.7 cr | ₹20.31 cr |
|---|
| Operating margin | 23.2% | 28.3% | 28.6% | 22.5% |
|---|
| Interest cost | ₹3.41 cr | ₹2.01 cr | ₹0.55 cr | ₹0.04 cr |
|---|
| Profit before tax | ₹24.01 cr | ₹31.27 cr | ₹38.16 cr | ₹22.58 cr |
|---|
| Tax expense | ₹6.26 cr | ₹8.2 cr | ₹10.05 cr | ₹5.56 cr |
|---|
| Effective tax rate | 26.0% | 26.2% | 26.3% | 24.6% |
|---|
| Net profit (PAT) | ₹17.76 cr | ₹23.07 cr | ₹28.11 cr | ₹17.02 cr |
|---|
| Net profit margin | 16.4% | 21.7% | 22.5% | 18.9% |
|---|
| Basic EPS | ₹13.83 | ₹17.96 | ₹22.34 | ₹14.01 |
|---|
| Diluted EPS | ₹13.83 | ₹17.96 | ₹22.34 | ₹14.01 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹14.36 cr against ₹24.67 cr in Q1 FY26, and ₹33.2 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -56.7%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹13.45 cr, or 93.7% of revenue, with operating profit declined -81.3% year on year.
Margins, tax and profitability
Net profit of ₹1.12 cr works out to a net margin of 7.8% compared with 14.0% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, Shree Ganesh Remedies Limited reported profit before tax of ₹1.53 cr, a tax charge of ₹0.41 cr (effective rate 26.8%), interest cost of ₹0.32 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹6.27 cr in Q4 FY26 to ₹1.12 cr in Q1 FY27, a change of -82.1%.
Trailing twelve months and annual context
Across the trailing four quarters Shree Ganesh Remedies Limited has generated revenue of ₹98.98 cr and net profit of ₹15.44 cr, a trailing net margin of 15.6%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹108 cr with net profit of ₹17.76 cr and EPS of ₹13.83, versus the prior year where revenue grew +1.5% and profit declined -23.0%.
What to watch in the next SGRL quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
Shree Ganesh Remedies Limited has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
SGRL results coverage
No results report published for SGRL yet — our desk covers each quarter within minutes of the filing.
SGRL quarterly results FAQs
What were Shree Ganesh Remedies Limited (SGRL) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), Shree Ganesh Remedies Limited reported revenue of ₹14.36 cr and net profit of ₹1.12 cr, a change of -67.5% year on year on -41.8% revenue growth. EPS stood at ₹0.87.
What is SGRL profit margin in Q1 FY27?
Shree Ganesh Remedies Limited posted a net profit margin of 7.8% and an operating margin of 6.3% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹98.98 cr and net profit ₹15.44 cr.
Did SGRL results beat the previous quarter?
Shree Ganesh Remedies Limited net profit changed -82.1% quarter on quarter, from ₹6.27 cr in Q4 FY26 to ₹1.12 cr in Q1 FY27.
When are Shree Ganesh Remedies Limited (SGRL) quarterly results?
Shree Ganesh Remedies Limited has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see SGRL latest quarterly results?
Results coverage for SGRL will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the SGRL stock page.
What is Shree Ganesh Remedies Limited annual revenue and profit?
For FY26, Shree Ganesh Remedies Limited reported full-year revenue of ₹108 cr and net profit of ₹17.76 cr, with EPS of ₹13.83.
How many quarterly results has SGRL declared recently?
Past results dates for SGRL will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
